Daniel Macuga Net Worth

The estimated Net Worth of Daniel A. Macuga is at least $2.6 Millón dollars as of 1 March 2024. Mr. Macuga owns over 1,500 units of Usana Health Sciences Inc stock worth over $141,328 and over the last 13 years he sold USNA stock worth over $1,510,788. In addition, he makes $946,074 as Chief Communications and Marketing Officer at Usana Health Sciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Macuga USNA stock SEC Form 4 insiders trading

Daniel has made over 36 trades of the Usana Health Sciences Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 3,791 units of USNA stock worth $178,708 on 2 May 2024.

The largest trade he's ever made was exercising 11,992 units of Usana Health Sciences Inc stock on 30 August 2017 worth over $345,490. On average, Daniel trades about 3,395 units every 104 days since 2012. As of 1 March 2024 he still owns at least 3,791 units of Usana Health Sciences Inc stock.

You can see the complete history of Mr. Macuga stock trades at the bottom of the page.

Daniel Macuga biography

Daniel A. Macuga Jr. serves as Chief Communications and Marketing Officer of the Company. Mr. Macuga joined USANA in 2007 as Vice President of Network Development and Public Relations. In July 2008, he was appointed as Vice President of Marketing, Public Relations and Social Media and served in that role until December 2011, when he was appointed Chief Communications Officer. He served in that role until February 2014 when he was appointed Chief Communications Officer and Executive Vice President of Field Development for the Americas. He served in that role until November 2016 when he was appointed Chief Communications Officer. He served in that position until November 2017 when he was named Chief Communications and Marketing Officer. Prior to joining USANA, Mr. Macuga was employed at the Chrysler Corporation, where he spent 15 years working closely with independent dealership entrepreneurs to help them build their businesses, increase awareness for their products, and keep them focused on effective customer relationship management. Mr. Macuga received a B.A. in communications from the University of California, San Diego.

What is the salary of Daniel Macuga?

As the Chief Communications and Marketing Officer of Usana Health Sciences Inc, the total compensation of Daniel Macuga at Usana Health Sciences Inc is $946,074. There are 7 executives at Usana Health Sciences Inc getting paid more, with Kevin Guest having the highest compensation of $4,157,830.

How old is Daniel Macuga?

Daniel Macuga is 50, he's been the Chief Communications and Marketing Officer of Usana Health Sciences Inc since 2017. There are 18 older and 4 younger executives at Usana Health Sciences Inc. The oldest executive at Usana Health Sciences Inc is Dr. Myron W. Wentz, 80, who is the Founder & Chairman Emeritus.

What's Daniel Macuga's mailing address?

Daniel's mailing address filed with the SEC is 3838 WEST PARKWAY BLVD., , SALT LAKE CITY, UT, 84120.

Insiders trading at Usana Health Sciences Inc

Over the last 28 years, insiders at Usana Health Sciences Inc have traded over $838,318,381 worth of Usana Health Sciences Inc stock and bought 4,600 units worth $120,973 . The most active insiders traders include Myron W Wentz, Global Ltd Gull y Myron W Gull Global Ltd Wentz. On average, Usana Health Sciences Inc executives and independent directors trade stock every 7 days with the average trade being worth of $572,994. The most recent stock trade was executed by Paul A. Jones on 13 August 2024, trading 6,266 units of USNA stock currently worth $240,489.

What does Usana Health Sciences Inc do?

usana health sciences’ mission is to develop and provide the highest quality, science-based health products, distributed internationally through network marketing, creating a rewarding financial opportunity for our independent associates, shareholders, and employees. we’ve got history. not baggage. we’ve been around since 1992, so we’re experienced (we’ve heard that’s a plus). and we look great for our age. plus, we have substance to go along with our great looks. we’ve got top-notch manufacturing facilities, our own scientists and research and development team, and the highest standards for our nutritional products. we have an award-winning compensation plan and award-winning products. we don’t like to brag, but we come pretty highly recommended. that’s because we got off on the right foot. we were founded by a scientist—not a corporate suit. usana’s founder, myron wentz, is an internationally recognized microbiologist, immunologist, and pioneer in infectious disease diagnosis. but su

Complete history of Mr. Macuga stock trades at Usana Health Sciences Inc

Usana Health Sciences Inc executives and stock owners

Usana Health Sciences Inc executives and other stock owners filed with the SEC include:

• Kevin Guest,
  Chairman of the Board, Chief Executive Officer
• Jim Brown,
  President
• Kevin G. Guest,
  Chairman & CEO
• G Hekking,
  Chief Financial Officer
• David Mulham,
  Chief Field Development Officer
• Walter Noot,
  Chief Operating Officer
• Jim Brown,
  Pres
• Daniel Macuga,
  Chief Communications and Marketing Officer
• G. Douglas Hekking,
  Chief Financial Officer
• David Mulham,
  Chief Sales Officer
• Walter Noot,
  Chief Operating Officer
• Paul Jones,
  Chief Leadership Development Officer
• Peggie Pelosi,
  Independent Director
• Gilbert Fuller,
  Lead Independent Director
• Robert Anciaux,
  Senior Director
• Frederic Winssinger,
  Independent Director
• Feng Peng,
  Independent Director
• Timothy Wood,
  Independent Director
• Dr. Myron W. Wentz,
  Founder & Chairman Emeritus
• John Fleming,
  Director
• Brent Neidig,
  Chief Officer and Managing Director of China
• P. Joshua Foukas,
  Chief Legal Officer, General Counsel and Corporate Secretary
• Robert Sinnott,
  Chief Scientific Officer
• P. Joshua Foukas,
  Chief Legal Officer, Gen. Counsel & Corp. Sec.
• Patrique Richards,
  Exec. Director of Investor Relations & Bus. Devel.
• Dr. John Cuomo,
  Exec. Director of Product Devel. & Technology
• J Scott Nixon,
  Director
• Myron W Gull Global Ltd Wentz,
  
• Robert Auciaux,
  
• Global Ltd Gull,
  10% owner
• Myron W Wentz,
  CEO
• Deborah Woo,
  E.V.P. of Sales
• Donald R. Williams,
  Director
• Dave Wentz,
  President
• James Bramble,
  
• Jerry G Mcclain,
  Director
• Denis E Waitley,
  Director
• Roy Truett,
  Chief Information Officer
• Doug Braun,
  Chief Marketing Officer
• Ronald S Poelman,
  Director
• Rick Stambaugh,
  Chief Information Officer
• Holdings Ltd Gull,
  10% owner
• Fred W Cooper,
  Vice President of Operations
• Jeffrey Yates,
  Chief Financial Officer
• Mark H Wilson,
  V.P. of Customer Relations
• Bradford Richardson,
  E.V.P. of Asia Pacific
• G Doug Iiekking,
  CHIEF FINANCIAL OFFICER
• Peter Benedict,
  CHIEF INFORMATION OFFICER
• Joshua Foukas,
  CHIEF LEGAL OFFICER
• Xia Ding,
  Director